Have a personal or library account? Click to login
Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches Cover

Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches

Open Access
|Sep 2018

Figures & Tables

Figure 1

Flow diagram of 26.556 non-attenders in the organised Slovenian cervical cancer screening programme ZORA, randomly selected from a screening registry for pilot implementation of HPV self-sampling and randomly allocated to the opt-in (I1), opt-out (I2) and control (P) study group.
Flow diagram of 26.556 non-attenders in the organised Slovenian cervical cancer screening programme ZORA, randomly selected from a screening registry for pilot implementation of HPV self-sampling and randomly allocated to the opt-in (I1), opt-out (I2) and control (P) study group.

Figure 2

Intention-to-screen response rate in study groups opt-in (I1), opt-out (I2) and comparison (P) by three types of response: HPV self-sampling (type A response), cytology screening with a PG only (type B response) or both (HPV self-sampling and cytology screening with a PG only, type C response).
Intention-to-screen response rate in study groups opt-in (I1), opt-out (I2) and comparison (P) by three types of response: HPV self-sampling (type A response), cytology screening with a PG only (type B response) or both (HPV self-sampling and cytology screening with a PG only, type C response).

Positive predictive value (PPV) of HPV test for CIN2+ and CIN3+ in women who had undergone colposcopy after a positive HPV test on self-collected sample and in women with concordant results of both HPV tests_ Results are stratified by the level of protection due to previous screening

Number of women withPPV
allcolposcopyCIN2+CIN3+CIN2+CIN3+
Positive result of HPV test on self-collected sample
  all women430333403212.0%9.6
  women with medium protection27922318128.1%5.4
  women with no/low protection151110222020.0%18.2
Concordant

Results of HPV tests were concordant, if HPV test on self-collected sample as well as sample taken by a practitioner were positive.

  all womenna

Results not available (na), since only women with colposcopy had a sample taken by a practitioner.

146342923.3%19.9
  women with medium protectionna97141014.4%10.3
  women with no/low protectionna49201940.8%38.8

The main results by their predictors_ Intention-to-screen response rates, the mean age of responders and histological outcomes are presented as absolute numbers, proportions (per 100 or 1_000) and 95% confidence intervals (CI) by the study group, the region of residence and the level of protection

Number of womenIntention to screen response rate per 100 (%) with 95% CIMean age (95% CI) of respondersIntetion to screen histology outcome
HSIL/CIN2+HSIL/CIN3+
no.per 1000 (‰) with 95% CIno.per 1000 (‰) with 95% CI
ALL WOMENAll women26,55633.8% (33.2%.34.4%)49.0 (48.7-49.2)943.5‰ (2.9‰–4.4‰)712.7‰ (2.1‰–3.4‰)
Responders8,972
STUDY GROUPSI1 opt-inall14,40034.0% (33.2%–34.8%)49.0 (48.7-49.3)493.4‰ (2.5‰–4.5‰)362.5‰ (1.8‰–3.5‰)
responders4,896
I2 opt-outall9,55637.7% (36.7%–38.6%)49.0 (48.6-49.3)373.9‰ (2.8‰–5.4‰)303.1‰ (2.2‰–4.5‰)
responders3,598
P controlall2,60018.4% (16.9%–19.9%)48.0 (47.2-48.9)83.1‰ (1.4‰–6.3‰)51.9‰ (0.7‰–4.8‰))
responders478
p-value< 0.000

Statistically significant result at α = 0.05.

0.7660.557
REGIONCeljeall11,05533.2% (32.3%–34.0%)48.3 (47.9-48.6)383.4‰ (2.5‰–4.8‰)282.5‰ (1.7‰–3.7‰)
responders3,666
Mariborall15,50134.2% (33.5%–35.0%)49.4 (49.2-49.7)563.6‰ (2.8‰–4.7‰)432.8‰ (2.0‰–3.8‰)
responders5,306
p-value0.0700.8130.708
LEVEL OF PROTECTIONMediumall12,46451.1% (50.2%–52.0%)48.4 (48.2-48.7)483.9‰ (2.9‰–5.1‰)332.6‰ (1.9‰–3.8‰)
responders6,367
No/lowall14,09218.5% (17.8%–19.1%)51.1 (50.9-51.3)463.3‰ (2.4‰–4.4‰)382.7‰ (1.9‰–3.7‰)
responders2,605
p-value< 0.000

Statistically significant result at α = 0.05.

0.4220.838

Response rate stratified by the level of protection due to previous screening_ Intention-to-screen response rates are presented as absolute numbers, proportions (per 100) and 95% confidence intervals (CI) by the study group and the region of residence

Level of protection
MediumNo/low
Number of womenResponse rate per 100 (%) with 95% CINumber of womenResponse rate per 100 (%) with 95% CI
STUDY GROUPSI1 opt-inall6,79651.5% (50.3%–52.7%)7,60418.3% (17.5%–19.2%)
responders3,5011,395
I2 opt-outall4,54054.8% (53.3%–56.2%)5,01622.2% (21.0%–23.3%)
responders2,4861,112
P controlall1,12833.7% (30.9%–36.5%)1,4726.7% (5.5%–8.1%)
responders38098
p-value< 0.000

Statistically significant result at α = 0.05.

< 0.000

Statistically significant result at α = 0.05.

REGIONCeljeall5,36150.4% (49.0%–51.7%)5,69417.0% (16.0%–18.0%)
responders2,700966
Mariborall7,10351.6% (50.5%–52.8%)8,39819.5% (18.7%–20.4%)
responders3,6671,639
p-value0.163< 0.000

Statistically significant result at α = 0.05.

Characteristics of women enrolled in the study

All randomly selected and allocated womenTotalSTUDY GROUPS
Number%I1 opt-inI2 opt-outP controlP-value
Number26,556100.014,4009,5562,600
Age49.8 (49.7-50.0)49.8 (49.7-50.0)49.8 (49.6-50.0)50.0 (49.6-50.3)
 Mean age (95% CI)
Level of protection
 medium12,46446.96,7964,540 1,1280.001

Statistically significant result at α = 0.05.

 no/low14,09253.17,6045,0161,472
Region
 Celje11,05541.65,9963,9841,0750.951
 Maribor15,50158.48,4045,5721,525
DOI: https://doi.org/10.2478/raon-2018-0036 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 399 - 412
Submitted on: May 20, 2018
|
Accepted on: Jul 13, 2018
|
Published on: Sep 14, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Urska Ivanus, Tine Jerman, Alenka Repse Fokter, Iztok Takac, Veronika Kloboves Prevodnik, Mateja Marcec, Ursula Salobir Gajsek, Maja Pakiz, Jakob Koren, Simona Hutter Celik, Kristina Gornik Kramberger, Ulrika Klopcic, Rajko Kavalar, Simona Sramek Zatler, Biljana Grcar Kuzmanov, Mojca Florjancic, Natasa Nolde, Srdjan Novakovic, Mario Poljak, Maja Primic Zakelj, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.